Can a walker help prevent falls in neuromuscular disease?
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests if using assistive walking devices, after a short training period, can lower the risk of falls in people with neuromuscular diseases. It aims to help you stay steady and safe on your feet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neuromuscular disease diagnosed by genetic testing or a doctor.
- You can understand and follow simple instructions.
- You are able to walk at least 10 meters (about 33 feet) without help.
- Your fear of falling is not severe (score 23 or less on a fall-related confidence scale).
- You have not had knee, hip, or back surgery in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a test to predict falls in people with neuromuscular disorders. You will fill out a questionnaire about your fall risk.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study tests a portable device that analyzes walking without markers. It aims to see if it can help assess walking in people with neuromuscular diseases and healthy volunteers, which could lead to simpler check-ups.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
This study looks at how children and teens with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) walk, by having them do walking tests while wearing sensors. The goal is to find better ways to track how these diseases progress and how treatments work over time, without needing blood tests or scans.
This study looks at how people with ALS walk while doing another task (like talking or counting). It aims to understand how the disease affects movement when you're focused on something else, which could help with future care.
Hear when a new Inclusion Body Myositis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.